Oritavancin in vitro activity against Gram-positive organisms from European medical centers: a 10-year longitudinal overview from the SENTRY Antimicrobial Surveillance Program (2010–2019).
- Resource Type
- Article
- Source
Journal of Chemotherapy (Taylor & Francis Ltd) . Dec2023, Vol. 35 Issue 8, p689-699. 11p.- Subject
- Language
- ISSN
- 1120-009X